NL-OMON21786
Recruiting
Not Applicable
Safety and effectiveness evaluation of the Minimal Invasive Deformity Correction (MID-C) System in adolescent idiopathic scoliosis
VU University Medical Center, Amsterdam, The Netherlands0 sites33 target enrollmentTBD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Surgical treatment of adolescent idiopathic scoliosis (AIS).
- Sponsor
- VU University Medical Center, Amsterdam, The Netherlands
- Enrollment
- 33
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Adolescent AIS patients (12 years \- 17 years old);
- •2\. Standing X\-ray: 40 to 55 degrees Cobb angle, Lenke type 1 or 5, Risser stage 1\-4;
Exclusion Criteria
- •1\.Other non\-idiopathic form of scoliosis;
- •2\.Primary curve Cobb angle \>55 degrees;
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Evaluation of the safety and effectiveness of the MID-C/ApiFix system in adolescent idiopathic scoliosis.Spinal curvature1002837710005944NL-OMON43676Vrije Universiteit Medisch Centrum33
Not yet recruiting
Phase 4
euroEPO in mild-moderate Alzheimer's disease amnesic variantmild-moderate Alzheimer's diseaseAlzheimer DiseaseDementiaBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesTauopathiesNeurodegenerative DiseasesNeurocognitive DisordersMental DisordersRPCEC00000410Center of Molecular Immunology (CIM)1,456
Active, not recruiting
Not Applicable
Safety and effectiveness clinical evaluation of the range of injectable medical devices HYDRAGEL C in facial aesthetic treatmentSubjects across groups present with moderate to severe facial aesthetic concerns, including peri-oral lines, nasolabial folds, lip volume deficits, and cheeks/cheekbones volume deficit, as gauged by various dermatological scalesSkin and Connective Tissue DiseasesISRCTN13586698ouna Aesthetics75
Active, not recruiting
Not Applicable
Clinical study to evaluate the safety and effectiveness of the use of two hyaluronic acid injectable products (Perfectha® Derm Lidocaine and Perfectha® Deep Lidocaine) in the treatment of lipsFor Perfectha® Derm Lidocaine: very thin to thin lip volume and with lip contour somewhat well-defined to poorly definedfor Perfectha® Deep Lidocaine: thin to moderate lip volumeNot ApplicableISRCTN72858148Sinclair Pharma68
Completed
Not Applicable
Evaluation of the safety and efficacy of the Optimizer™ II and III systems with active fixation leads in subjects with heart failure resulting from systolic dysfunctioHeart failureCirculatory SystemISRCTN16213127Impulse Dynamics Inc. (USA)250